UroGen Pharma (URGN) Current Assets: 2016-2025
Historic Current Assets for UroGen Pharma (URGN) over the last 9 years, with Sep 2025 value amounting to $168.5 million.
- UroGen Pharma's Current Assets fell 42.88% to $168.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.5 million, marking a year-over-year decrease of 42.88%. This contributed to the annual value of $276.1 million for FY2024, which is 63.21% up from last year.
- As of Q3 2025, UroGen Pharma's Current Assets stood at $168.5 million, which was down 14.39% from $196.9 million recorded in Q2 2025.
- In the past 5 years, UroGen Pharma's Current Assets registered a high of $295.1 million during Q3 2024, and its lowest value of $81.3 million during Q2 2023.
- Its 3-year average for Current Assets is $198.0 million, with a median of $196.8 million in 2024.
- In the last 5 years, UroGen Pharma's Current Assets soared by 242.99% in 2024 and then plummeted by 42.88% in 2025.
- Over the past 5 years, UroGen Pharma's Current Assets (Quarterly) stood at $114.4 million in 2021, then increased by 12.69% to $128.9 million in 2022, then spiked by 31.25% to $169.2 million in 2023, then spiked by 63.21% to $276.1 million in 2024, then plummeted by 42.88% to $168.5 million in 2025.
- Its Current Assets stands at $168.5 million for Q3 2025, versus $196.9 million for Q2 2025 and $237.2 million for Q1 2025.